+91-9019923542 / 41 / 43 info@chromedbio.comKIADB Industrial Area, Hirehalli, Tumakuru - 572168. India.

Investor Relations

Pioneering Drug Discovery & Global Preclinical Excellence

Welcome to the Chromed Biosciences Private Limited Investor Relations portal. We are an emerging Contract Research Organization (CRO) delivering high-throughput drug discovery, screening support, preclinical testing, and global regulatory compliance solutions.

Global Vision & Regulatory Standard

Chromed Biosciences is expanding its global footprint to directly support CDSCO, US FDA, EMA, and global market regulatory filings. Our facility compliance and quality systems are engineered to international regulatory benchmarks:

CDSCO

NABL

US FDA

OECD GLP

End-to-End Service Portfolio & Divisions

We serve global pharmaceutical, biotechnology, agrochemical, veterinary, and nutraceutical enterprises through a diversified multi-disciplinary testing ecosystem:

US FDA & Global Dossier Submissions
Utilizing upcoming OECD GLP capabilities to capture high-value regulatory dossier contracts from US, European, and Asian biotech firms.
Alternative-to-Animal Testing Leadership
Positioning Chromed Biosciences at the forefront of 3D cell culture and bio-emulation models to meet global demand for humane, highly predictive pre-clinical research.
Capacity Expansion

Continuous scaling of specialized bio-containment units for virology research and advanced analytical laboratory and F&D.

Investor Resources

Investing in Chromed Biosciences Private Limited offers a high-impact opportunity in the expanding global CRO market through a fully accredited, one-stop R&D partner. Backed by NABL accreditation, CDSCO approval, and an active transition to OECD GLP certification, we deliver regulatory-compliant data for global approvals across US FDA, EMA, EPA, and FSSAI frameworks. Our integrated capabilities span drug discovery, virology, agrochemical, veterinary, and nutraceutical testing—featuring cutting-edge animal-alternative 3D organoid and Organ-on-a-Chip technologies aligned with the US FDA Modernization Act 2.0. Strategically located near Bengaluru’s biotech hub, our diversified service model ensures high client retention, cost-effective scalability, and sustainable margin growth..

Contact Investor Relations

We welcome engagement with institutional investors, venture capital funds, and strategic industry partners seeking growth in global CRO services.